Eur Rev Med Pharmacol Sci 2020; 24 (24): 13000-13008

DOI: 10.26355/eurrev_202012_24205

Microbiota and microRNAs in lung diseases: mutual influence and role insights

M. Casciaro, E. Di Salvo, G. Pioggia, S. Gangemi

Department of Experimental Medicine, School and Operative Unit of Allergy and Clinical Immunology, University of Messina, Messina, Italy. gangemis@unime.it


Trillions of microbial cells colonize human body both internally and externally. The prevalent amount of these reside in the gastrointestinal tract (gut microbiome). Gut microflora support the transformation of food nutrients. The products of this modification processes both modulate gastro-intestinal immunity, and influence other organs such as lung and brain. Recently, it was reported the role of micro-RNAs (miRNAs) as regulators in different pathways of the innate and/or adaptive immune responses. Latest studies discussed the aptitude of probiotics strains to balance the host immune response at a post-transcriptional level by controlling miRNAs expression. We speculated a model of lung immune regulation driven by the axis microbiota-microRNAs, involving asthma, acute injury, cancer and COPD. Based on this axis, we propose a novel approach based on the modification of microRNAs expression centered not exclusively on antagomiRs but also on microbiota modification in order to further potentiate their therapeutic effects.

Free PDF Download

To cite this article

M. Casciaro, E. Di Salvo, G. Pioggia, S. Gangemi
Microbiota and microRNAs in lung diseases: mutual influence and role insights

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 24
Pages: 13000-13008
DOI: 10.26355/eurrev_202012_24205